These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15258784)

  • 21. Emboli and cognitive state in surgical vs. transcatheter aortic valve replacement.
    Friedman T; Cohen O; Ziser A; Kerner A; Bitton-Worms K; Bolotin G
    Asian Cardiovasc Thorac Ann; 2017 Jul; 25(6):425-431. PubMed ID: 28648116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
    J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure.
    Spencer MP; Moehring MA; Jesurum J; Gray WA; Olsen JV; Reisman M
    J Neuroimaging; 2004 Oct; 14(4):342-9. PubMed ID: 15358955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome.
    Post MC; Van Deyk K; Budts W
    Acta Cardiol; 2005 Oct; 60(5):515-9. PubMed ID: 16261783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.
    Ostermayer SH; Srivastava S; Doucette JT; Ko HH; Geiger M; Parness IA; Love BA
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1195-203. PubMed ID: 26332722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine.
    Sevgi EB; Erdener SE; Demirci M; Topcuoglu MA; Dalkara T
    J Am Heart Assoc; 2012 Dec; 1(6):e001735. PubMed ID: 23316313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous transcatheter closure of patent foramen ovale.
    Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
    Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical closure of combined symptomatic patent foramen ovale and atrial septum aneurysm for prevention of recurrent cerebral emboli.
    Klotz S; Tjan TD; Berendes E; Droste DW; Scheld HH; Schmid C
    J Card Surg; 2005; 20(4):370-4. PubMed ID: 15985142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patent foramen ovale and left atrial appendage: new devices and methods for closure.
    Hein R; Bayard Y; Taaffe M; Büscheck F; Ostermayer S; Billinger K; Reschke M; Trepels T; Lissmann-Jensen H; Lang K; Römer A; Wilson N; Sievert H
    Pediatr Cardiol; 2005; 26(3):234-40. PubMed ID: 16132300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.